Literature DB >> 15074637

Paratuberculosis: eradication, control and diagnostic methods.

G Benedictus1, C J H Kalis.   

Abstract

At the beginning of the twentieth century, the dairy industry and cattle breeding organisations initiated a programme to control infectious diseases by means of a complex system of rewards and penalties. The history of programmes to control paratuberculosis in sheep, goats, and cattle in various countries is described. The vaccination of young animals (especially goats and sheep) seems to be an effective measure in the prevention of clinical paratuberculosis, although changes in management and hygiene practices are also important. A control programme for infectious cattle diseases has a number of phases (a life cycle) and different components. Two components are essential for success, namely, open and regular communication with farmers, veterinary practitioners, and other people involved, and a good registration and identification system for cattle, herds, and veterinary practitioners. The principles and different levels of control of paratuberculosis are discussed. The Dutch paratuberculosis programme is divided in two parts: an intensive programme based on test and cull and an extensive programme based on education. The intensive programme has ten herd status levels: 5 to 10 for non?suspect herds and 1 to 4 for infected herds or herds of unknown status. The higher the status, the greater the chance that a herd is free of paratuberculosis. An outline is given of the Dutch paratuberculosis programme. Diagnostic methods are summarised. Future developments regarding vaccination and control or acceptance of paratuberculosis are discussed.

Entities:  

Mesh:

Year:  2003        PMID: 15074637

Source DB:  PubMed          Journal:  Acta Vet Scand        ISSN: 0044-605X            Impact factor:   1.695


  8 in total

Review 1.  Johne's disease in Canada part II: disease impacts, risk factors, and control programs for dairy producers.

Authors:  Shawn L B McKenna; Greg P Keefe; Ashwani Tiwari; John VanLeeuwen; Herman W Barkema
Journal:  Can Vet J       Date:  2006-11       Impact factor: 1.008

2.  Peptide aMptD-mediated capture PCR for detection of Mycobacterium avium subsp. paratuberculosis in bulk milk samples.

Authors:  Janin Stratmann; Karen Dohmann; Julia Heinzmann; Gerald-F Gerlach
Journal:  Appl Environ Microbiol       Date:  2006-08       Impact factor: 4.792

3.  Factors affecting isolation and identification of Mycobacterium avium subsp. paratuberculosis from fecal and tissue samples in a liquid culture system.

Authors:  Richard J Whittington
Journal:  J Clin Microbiol       Date:  2009-01-14       Impact factor: 5.948

4.  A new compartmental model of Mycobacterium avium subsp. paratuberculosis infection dynamics in cattle.

Authors:  Rebecca L Smith; Ynte H Schukken; Yrjö T Gröhn
Journal:  Prev Vet Med       Date:  2015-10-21       Impact factor: 2.670

5.  Clinical, ultrasonographic, and pathologic findings in 70 camels (Camelus dromedarius) with Johne's disease.

Authors:  Mohamed Tharwat; Fahd Al-Sobayil; Ahmed Ali; Mahmoud Hashad; Sébastien Buczinski
Journal:  Can Vet J       Date:  2012-05       Impact factor: 1.008

6.  Ovine paratuberculosis: a seroprevalence study in dairy flocks reared in the marche region, Italy.

Authors:  Attili Anna Rita; Ngu Ngwa Victor; Preziuso Silvia; Pacifici Luciana; Domesi Anastasia; Cuteri Vincenzo
Journal:  Vet Med Int       Date:  2011-08-24

7.  Intestinal infection following aerosol challenge of calves with Mycobacterium avium subspecies paratuberculosis.

Authors:  Susanne W F Eisenberg; Ad P Koets; Mirjam Nielen; Dick Heederik; Rienske Mortier; Jeroen De Buck; Karin Orsel
Journal:  Vet Res       Date:  2011-12-03       Impact factor: 3.683

8.  Dam Mycobacterium avium subspecies paratuberculosis (MAP) infection status does not predetermine calves for future shedding when raised in a contaminated environment: a cohort study.

Authors:  Susanne W F Eisenberg; Victor P M G Rutten; Ad P Koets
Journal:  Vet Res       Date:  2015-06-19       Impact factor: 3.683

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.